Prosecution Insights
Last updated: April 19, 2026

Sunshine Lake Pharma Co. Ltd.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
2
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18037105 SALTS OF DIHYDROPYRIMIDINE DERIVATIVES, COMPLEXES AND USES THEREOF IN MEDICINE DAHLIN, HEATHER RAQUEL 1629 Non-Final OA May 16, 2023
18028029 VIRAL VECTORS AND USES THEREOF SMALL, KATHERINE R 1633 Non-Final OA Mar 23, 2023
17627025 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF GURLEY, JAMI MICHELLE 1647 Final Rejection Jan 13, 2022
17311784 A VILAZODONE SOLID DISPERSION AND PREPARATION METHOD THEREOF WARD, PAUL V 1622 Final Rejection Nov 26, 2021
17604728 ANTI-TRKA ANTIBODIES AND USES THEREOF ALSOMAIRY, SARAH ABDOALATIF 1646 Non-Final OA Oct 18, 2021

Managing Sunshine Lake Pharma Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month